Asian Conference on Tumor Ablation Guidelines for Hepatocellular Carcinoma

Area of Science:

• Hepatology
• Interventional Radiology
• Oncology

Background:

• Global incidence and mortality of primary liver cancer are increasing.
• Hepatocellular carcinoma (HCC) predominantly affects Asia, with 80% of cases originating there.
• Curative resection is only feasible for 20% of patients, necessitating alternative treatments.

Purpose of the Study:

• To establish comprehensive guidelines for hepatocellular carcinoma (HCC) management using image-guided percutaneous liver tumor ablation.
• To standardize the application of ablation techniques given variations in operator skill and the high volume of procedures in Asia.
• To provide a framework for indications, diagnosis, planning, technique, management, evaluation, complications, follow-up, and recurrence treatment for HCC ablation.

Main Methods:

• Development of guidelines by the Asian Conference on Tumor Ablation.
• Inclusion of comprehensive aspects of ablation: indications, pre-ablative assessment, techniques, peri-ablative care, efficacy evaluation, complication management, and follow-up strategies.
• Focus on recurrence prevention and treatment strategies for HCC.

Main Results:

• The guidelines cover the full spectrum of percutaneous liver tumor ablation for HCC.
• Emphasis on standardized approaches to improve patient outcomes.
• Addresses the unique challenges and high prevalence of HCC ablation in Asia.

Conclusions:

• Image-guided percutaneous liver tumor ablation is a primary treatment for early-stage HCC.
• Standardized guidelines are crucial due to the increasing incidence of HCC and variations in ablation techniques.
• These guidelines aim to optimize the effectiveness and safety of HCC ablation worldwide, particularly in Asia.